Traws Pharma (TRAW) Retained Earnings (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Retained Earnings of -$2000.0 for Q1 2026, up 100.0% year-over-year from -$1000.0 in Q1 2025, and down 133.33% quarter-over-quarter from $6000.0 in Q4 2025.
Traws Pharma (TRAW) Retained Earnings (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Retained Earnings for 15 consecutive years, with -$2000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 100.0% year-over-year to -$2000.0; the TTM figure through Mar 2026 stood at -$2000.0 (up 100.0% YoY), while the FY2025 annual figure was $6000.0, up 100.0% from the prior year.
- Retained Earnings eased to -$2000.0 in Q1 2026 per TRAW's latest filing, from $6000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $6000.0 in Q3 2025 and bottomed at -$649.2 million in Q4 2024.
- Historically, Retained Earnings has averaged -$378.2 million across 5 years, with a median of -$473.7 million in 2023.
- Annual changes were most pronounced in 2023 — Retained Earnings slumped 1462418.18% — and 2025, when it soared 100.0%.
- Traws Pharma's Retained Earnings stood at -$33000.0 in 2022, then plunged by 1462418.18% to -$482.6 million in 2023, then plunged by 34.5% to -$649.2 million in 2024, then surged by 100.0% to $6000.0 in 2025, then sank by 133.33% to -$2000.0 in 2026.
- Business Quant data shows TRAW's Retained Earnings at -$2000.0 in Q1 2026, $6000.0 in Q4 2025, and $6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - | -650.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | -628.58 Mn |
| Mar 31, 2025 | -627.66 Mn |
| Dec 31, 2024 | -649.15 Mn |
| Sep 30, 2024 | -619.23 Mn |
| Jun 30, 2024 | -610.76 Mn |
| Mar 31, 2024 | -487.61 Mn |
| Dec 31, 2023 | -482.63 Mn |
| Sep 30, 2023 | -478.45 Mn |
| Jun 30, 2023 | -473.71 Mn |
| Mar 31, 2023 | -469.46 Mn |
| Dec 31, 2022 | -33,000.00 |
| Sep 30, 2022 | -61,000.00 |
| Jun 30, 2022 | -452.87 Mn |
| Mar 31, 2022 | -448.84 Mn |
| Dec 31, 2021 | -444.72 Mn |
| Sep 30, 2021 | -6,000.00 |
| Jun 30, 2021 | -437.50 Mn |